BioNTech SE (BNTX) Total Debt (2018 - 2025)

BioNTech SE has disclosed Total Debt across 8 years of filings, most recently posting $409.4 million for Q4 2025.

• Total Debt for Q4 2025 came in at $409.4 million, down 74.29% year-over-year; the trailing twelve-month figure through Dec 2025 was $409.4 million (down 74.29% YoY), and the FY2025 annual result was $397.4 million, down 75.05% from the prior year.
• Total Debt came in at $409.4 million for Q4 2025 at BioNTech SE, down from $698.4 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $1.6 billion in Q4 2024 to a low of $37.3 million in Q3 2022.
• The 5-year median for Total Debt is $437.9 million (2025), against an average of $590.7 million.
• Peak annual rise in Total Debt reached 838.43% in 2023, while the deepest fall reached 78.19% in 2023.
• BioNTech SE's Total Debt stood at $1.6 billion in 2021, then sank by 48.42% to $807.2 million in 2022, then plunged by 39.49% to $488.5 million in 2023, then soared by 226.02% to $1.6 billion in 2024, then tumbled by 74.29% to $409.4 million in 2025.
• The last three Total Debt figures came in at $409.4 million (Q4 2025), $698.4 million (Q3 2025), and $164.1 million (Q2 2025), per Business Quant data.